Fred R. Hirsch
Fred R. Hirsch, MD, PhD

Executive director, Center for Thoracic Oncology, Mount Sinai Cancer, Mount Sinai Health System;

Professor of medicine and pathology, Icahn School of Medicine;

Joe Lowe and Louis Price Professor of Medicine,

Associate director, Tisch Cancer Institute

Latest Stories

ClinicalTrials & Tribulations
This story is part of The Cancer Letter's ongoing coverage of COVID-19's impact on oncology. A full list of our coverage is available here.
FreeGuest Editorial
This story is part of The Cancer Letter's ongoing coverage of COVID-19's impact on oncology. A full list of our coverage, as well as the latest meeting cancellations, is available here.The COVID-19 pandemic has created a host of diagnostic, treatment, and follow-up problems for patients with cancer of all types, and this is particularly true for patients with lung cancer, their families, and health care providers.
ClinicalTrials & Tribulations
We were recently presented with the new report from American Cancer Society1 showing the biggest annual decrease in cancer mortality, which was mainly due to decline in smoking, as well as improvements in early detection and treatment.
ClinicalFreeTrials & Tribulations
Despite much progress in lung cancer over the last decade, lung cancer is the most frequent cause of cancer death.